Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ribozyme, Chiron initiate product development of RPI-4610

Nov. 14, 1997

ImClone receives SBIR grant for angiogenesis research

Nov. 14, 1997

Potent antineoplastic camptothecin derivative identified

Nov. 14, 1997

TK inhibitors under development at Dr. Karl Thomae

Nov. 13, 1997

Sankyo synthesizes azole aromatase inhibitors

Nov. 13, 1997

Mitsui Toatsu reveals novel antitumor agents

Nov. 12, 1997

Radicicol derivatives with antitumor activity from Sankyo

Nov. 12, 1997

MDR-reversing agents reported by Nikken Chemicals

Nov. 12, 1997

Spotlight on topoisomerase I inhibitors

Nov. 12, 1997

DepoCyt to be reviewed by FDA advisory committee this month

Nov. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.